Advertisement
Canada markets open in 7 hours 3 minutes

  • S&P/TSX

    21,873.72
    -138.00 (-0.63%)
     

  • S&P 500

    5,071.63
    +1.08 (+0.02%)
     

  • DOW

    38,460.92
    -42.77 (-0.11%)
     

  • CAD/USD

    0.7309
    +0.0012 (+0.16%)
     

  • CRUDE OIL

    82.97
    +0.16 (+0.19%)
     

  • Bitcoin CAD

    87,958.95
    -3,226.23 (-3.54%)
     

  • CMC Crypto 200

    1,391.15
    +8.57 (+0.62%)
     

  • GOLD FUTURES

    2,330.10
    -8.30 (-0.35%)
     

  • RUSSELL 2000

    1,995.43
    -7.22 (-0.36%)
     

  • 10-Yr Bond

    4.6520
    +0.0540 (+1.17%)
     

  • NASDAQ futures

    17,429.50
    -235.00 (-1.33%)
     

  • VOLATILITY

    15.97
    +0.28 (+1.78%)
     

  • FTSE

    8,040.38
    -4.43 (-0.06%)
     

  • NIKKEI 225

    37,628.48
    -831.60 (-2.16%)
     

  • CAD/EUR

    0.6815
    -0.0004 (-0.06%)
     

Today's Research Reports on Knight Therapeutics, Covalon Technologies, Cotinga Pharmaceuticals and Baylin Technologies

ACCESSWIRE

NEW YORK, NY / ACCESSWIRE / August 27, 2018 / Research Driven Investing strives to provide investors with free daily equity research reports analyzing major market events. Take a few minutes to register with us free at http://rdinvesting.com and get exclusive access to our numerous research reports and market updates.

RDI Initiates Coverage on:

Knight Therapeutics Inc.
https://rdinvesting.com/news/?ticker=GUD.TO

Covalon Technologies Ltd.
https://rdinvesting.com/news/?ticker=COV.V

Cotinga Pharmaceuticals Inc.
https://rdinvesting.com/news/?ticker=COT.V

Baylin Technologies Inc.
https://rdinvesting.com/news/?ticker=BYL.TO

ADVERTISEMENT

Knight Therapeutics' stock edged 0.59% higher Friday, to close the day at $8.48. The stock recorded a trading volume of 55,250 shares, which was below its three months average volume of 106,612 shares. In the last year, Knight Therapeutics' shares have traded in a range of 7.38 - 9.11. The stock is currently trading 6.92% below its 52 week high. The company's shares are currently trading above their 200-day moving average. The stock's 50-day moving average of $8.44 is greater than its 200-day moving average of $8.04. Shares of Knight Therapeutics are trading at a Price to Earnings ratio of 56.16. Shares of Knight Therapeutics have gained approximately 2.05 percent year-to-date.

Access RDI's Knight Therapeutics Inc. Research Report at:
https://rdinvesting.com/news/?ticker=GUD.TO

On Friday, shares of Covalon Technologies recorded a trading volume of 56,860 shares, which was above the three months average volume of 30,101 shares. The stock ended the day 2.03% lower at 7.24. The share price has gained 201.67% from its 52 week low with a 52 week trading range of 2.40 - 9.41. The company's shares are currently trading above their 200-day moving average. The stock's 50-day moving average of $8.00 is greater than its 200-day moving average of $6.31. Shares of Covalon Technologies are trading at a Price to Earnings ratio of 181.00. Shares of Covalon Technologies have gained approximately 48.06 percent year-to-date.

Access RDI's Covalon Technologies Ltd. Research Report at:
https://rdinvesting.com/news/?ticker=COV.V

Cotinga Pharmaceuticals' stock moved 1.25% lower Friday, to close the day at $0.395. The stock recorded a trading volume of 4,400 shares, which was below its three months average volume of 10,965 shares. In the last year, Cotinga Pharmaceuticals' shares have traded in a range of 0.29 - 1.50. The share price has gained 36.21% from its 52 week low. The company's shares are currently trading below their 200-day moving average. The stock's 50-day moving average of $0.44 is below its 200-day moving average of $0.56. Shares of Cotinga Pharmaceuticals have fallen approximately 63.08 percent year-to-date.

Access RDI's Cotinga Pharmaceuticals Inc. Research Report at:
https://rdinvesting.com/news/?ticker=COT.V

On Friday, shares of Baylin Technologies recorded a trading volume of 20,950 shares, which was below the three months average volume of 25,396 shares. The stock ended the day 7.35% higher at 3.65. The share price has gained 95.19% from its 52 week low with a 52 week trading range of 1.87 - 4.12. The company's shares are currently trading above their 200-day moving average. The stock's 50-day moving average of $3.39 is below its 200-day moving average of $3.52. Shares of Baylin Technologies have gained approximately 6.1 percent year-to-date.

Access RDI's Baylin Technologies Inc. Research Report at:
https://rdinvesting.com/news/?ticker=BYL.TO

Our Actionable Research on Knight Therapeutics Inc. (TSX: GUD.TO) and Covalon Technologies Ltd. (TSX-V: COV.V) and Cotinga Pharmaceuticals Inc. (TSX-V:COT.V) and Baylin Technologies Inc. (TSX: BYL.TO) can be downloaded free of charge at Research Driven Investing.

Research Driven Investing

We are committed to providing relevant and actionable information for the self-directed investor. Our research is reputed for being a leader in trusted, in-depth analysis vital for informed strategic trading decisions. The nimble investor can leverage our analysis and collective expertise to execute a disciplined approach to stock selection.

RDInvesting has not been compensated; directly or indirectly; for producing or publishing this document.

Disclaimer: This article is written by an independent contributor of RDInvesting.com and Nadia Noorani, a CFA® charter holder, has provided necessary guidance in preparing the document templates. RDInvesting.com is neither a registered broker-dealer nor a registered investment advisor. For more information please read our full disclaimer at www.rdinvesting.com/disclaimer.

CONTACT

For any questions, inquiries, or comments reach out to us directly at:

Address:

Email:

contact@rdinvesting.com

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: RDInvesting.com